Recruiting

Interoceptive Intervention for Pulmonary Hypertension

ClinicalTrials.gov IDNCT06443580

PhaseNA

Enrollment32

SponsorGolden Jubilee National Hospital

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Interoception, Pulmonary Hypertension

About this study

Background Pulmonary hypertension is a rare and incurable condition characterised by fatigue and breathlessness. The effects of pulmonary hypertension has a significant impact on an individual's emotional wellbeing and there are currently no established psychological interventions to improve this. Interoception is defined as the ability to perceive the internal state of the body and emerging research suggests that interventions to improve interoception can improve well-being. Aims The project aims to develop an interoceptive based intervention for those with pulmonary hypertension and examine the feasibility and acceptability of this. Additional aims are to explore the preliminary results of the intervention. Methods A randomised control feasibility trial will be used. Thirty-two participants will be included. Participants will be patients within the Scottish Pulmonary Vascular Unit diagnosed with pulmonary hypertension and randomly assigned to either the intervention or control (waitlist) group. The intervention will be an eight-session online group and participants will complete measures for interoception, anxiety, depression, health related quality of life, as well as a feasibility and acceptability questionnaire. Quantitative analysis will include descriptive statistics and T-tests (including non-parametric versions) to analyse the feasibility and gain a preliminary understanding of the intervention. Practical Applications It is hoped that the findings will identify a sample size for a larger trial whilst also informing future clinical practice. This project will be written up for a suitable journal and will be presented at an appropriate conference.

Interventions

Other: interoceptive group based intervention — 8 week online group intervention aiming to improve interoception.

Primary outcomes

Multidimensional Assessment of Interoceptive Awareness (MAIA-2) (baseline (up to 4 weeks prior to intervention starting) and 8 weeks (during last intervention session))

Eligibility information

Inclusion Criteria: * Participants will be patients under the care of the Scottish Pulmonary Vascular Unit (SPVU) at the Golden Jubilee University National Hospital (GJUNH). * Diagnosed with any type of PH. * Adults over 18 years. * Fluent in English. * Able to commit to the duration of the research (expected to be three months from initial recruitment to the end of treatment). Exclusion Criteria: * Individuals with current thoughts of self-harm or suicide. * Presenting with comorbid alcohol or substance misuse. * Currently engaging in any additional psychological interventions at the time of the study.

Study locations

Golden Jubilee National Hospital, Glasgow, Clydebank g81 4dy United Kingdom

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.